Inspiratory Muscle Training for Heart Failure
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a specific breathing exercise, called inspiratory muscle training, can help people with heart failure improve their breathing during exercise. Participants will perform this exercise at either high or very low intensity for comparison. Individuals experiencing heart failure symptoms, taking specific heart failure medications, and able to exercise without major physical limitations might be suitable for this trial.
As an unphased trial, this study provides a unique opportunity to contribute to understanding innovative approaches to managing heart failure symptoms.
Do I need to stop my current medications for the trial?
The trial requires participants to have been taking SGLT2 inhibitors and spironolactone (and beta-blockers for certain patients) for more than 3 months, so you will need to continue these medications. The protocol does not specify if you need to stop any other medications.
What prior data suggests that inspiratory muscle training is safe for heart failure patients?
Research has shown that Inspiratory Muscle Training (IMT) is generally safe for people with heart failure. Studies have found that IMT can improve breathing and increase exercise capacity without causing serious side effects. People with chronic heart failure who used IMT reported easier exercise and felt less tired and out of breath.
Additionally, no major negative effects have been commonly linked to IMT, indicating that patients tolerate it well. Those considering joining a trial should discuss any concerns with their healthcare provider.12345Why are researchers excited about this trial?
Inspiratory Muscle Training (IMT) is unique because it strengthens the muscles used for breathing, unlike traditional heart failure treatments that focus on medications like ACE inhibitors, beta-blockers, or diuretics to manage symptoms and improve heart function. Researchers are excited about IMT because it directly enhances respiratory muscle strength, potentially improving patient endurance and quality of life. This non-drug approach offers a promising complementary option to existing therapies, addressing a different aspect of heart failure management by focusing on breathing efficiency.
What evidence suggests that inspiratory muscle training is effective for heart failure?
Research has shown that inspiratory muscle training (IMT) can help people with heart failure. In this trial, participants will divide into two groups: one receiving IMT at 40% maximal inspiratory pressure and another receiving a sham treatment at 2% maximal inspiratory pressure. Studies have found that IMT strengthens breathing muscles and improves the quality of life for these patients. It also lowers certain heart-related markers, indicating better heart health. Other research suggests that IMT improves blood flow to both resting and active limbs in people with chronic heart failure, potentially aiding circulation during physical activity. Overall, promising evidence indicates that IMT can benefit heart failure patients.678910
Who Is on the Research Team?
Joshua Smith, PhD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for adults over 18 with heart failure who can exercise, have a BMI ≤40 kg/m2, and are non-smokers or have quit smoking with less than a 20 pack-year history. They must be on certain heart medications for more than 3 months. Pregnant women, current heavy smokers, those with severe asthma or liver issues, and individuals with recent serious heart rhythm problems cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo inspiratory muscle training at specified intensities for 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Inspiratory Muscle Training
Inspiratory Muscle Training is already approved in European Union, United States, Canada for the following indications:
- Chronic Obstructive Pulmonary Disease (COPD)
- Congestive Heart Failure
- Spinal Cord Injury
- Multiple Sclerosis
- Chronic Obstructive Pulmonary Disease (COPD)
- Congestive Heart Failure
- Spinal Cord Injury
- Multiple Sclerosis
- Cardiac Rehabilitation
- Chronic Obstructive Pulmonary Disease (COPD)
- Congestive Heart Failure
- Spinal Cord Injury
- Multiple Sclerosis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator